Hikma Pharmaceuticals is trading in a bullish trend and several arguments are in favor of the continuation of this trend.

The company shows strong fundamentals. Firstly, the high valuation of the group shows a great investors confidence in it because there are willing to pay a high price for the stock. Moreover, the consensus revised upward EPS estimates for this year and that let see a great potential for the security on the stock market.

Technical patterns are in the green: prices are up for several months. The movement should continue in the coming trading sessions. The 20-hour moving average should help to reach the GBp 2470 long term resistance.

For reasons above exposed, investors could benefit from the upward trend on Hikma Pharmaceuticals by opening long positions. A first target could be set at the GBp 2470 and new bullish aim could be further reached. The return under GBp 2341 would invalidate the recovery scenario and trigger the stop-loss order.